Key Takeaways Epithalon and Epitalon generally refer to the synthetic AEDG tetrapeptide
Weight Loss Semaglutide: A New Approach to Weight Loss Semaglutide, a medication originally developed to treat type 2 diabetes, has gained significant attention for its potential to aid in weight loss
Semaglutide: A Research Overview A structure-first reference on semaglutide, tracing how fatty-diacid acylation, a DPP-4-resistant Aib substitution, and the SNAC oral-delivery system emerged from three decades of GLP-1 analogue engineering at Novo Nordisk
Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting Oxidative Stress
Biomarker Development Multi-marker panels combining serum proteins, metabolites, and microRNAs show improved diagnostic performance compared to single biomarkers
Currently, there is a significant knowledge gap in the industry about the effects of weight-loss medications, which is why this GLP-1 course has been created